好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Ictal–interictal Continuum and Inflammatory Encephalopathy as the Initial Presentation of CNS Hemophagocytic Lymphohistiocytosis
Neuro-oncology
P3 - Poster Session 3 (5:00 PM-6:00 PM)
6-002
Hemophagocytic lymphohistiocytosis is a rare multisystem disorder characterized by proliferation and diffuse infiltration multiple organs with histiocytes, including the central nervous system.  To emphasize that IIC with inflammatory cerebrospinal fluid (CSF) indices and EEG abnormalities may represent the earliest manifestation of CNS-HLH, warranting urgent immunochemotherapeutic intervention.

A previously healthy adult male was hospitalized three times within one month for recurrent pancytopenia, abdominal pain, and transient encephalopathy that resolved spontaneously. On his third admission, he developed neutropenic fever, acute kidney injury, and rapidly progressive encephalopathy with myoclonic jerks. Brain MRI was unremarkable. Continuous EEG showed generalized periodic discharges at 1.5–2 Hz with superimposed sharply contoured morphology, consistent with an ictal–interictal continuum pattern. A trial of IV lorazepam led to attenuation of discharges and transient improvement, but his EEG and clinical status continued to worsen despite antiseizure therapy. CSF demonstrated lymphocytic pleocytosis (687/µL), elevated protein (139 mg/dL), and normal glucose. Infectious, autoimmune, metabolic, and toxicologic workup was negative. In contrast, hemophagocytic markers were markedly elevated (H-score 206, high soluble IL-2 receptor, elevated CXCL9 and CRP, low haptoglobin, positive DAT). Flow cytometry revealed CD4+ T-cell expansion, consistent with secondary hemophagocytic lymphohistiocytosis (HLH) with CNS involvement. Bone marrow biopsy showed normocellular trilineage hematopoiesis with erythroid predominance and no malignancy.

none
Empiric intrathecal methotrexate and systemic dexamethasone/etoposide produced rapid clinical and electrographic improvement, confirming that CNS-HLH encephalopathy. No secondary trigger was identified. Repeat CSF analysis showed marked improvement, highlighting the critical role of early neuro-immunologic detection and intervention in CNS-HLH.

CNS-HLH may present as inflammatory encephalopathy with IIC patterns. Early EEG recognition and prompt immunochemotherapy can enable rapid neurologic recovery and normalization of CSF markers, emphasizing the need to consider CNS-HLH in patients with hyperinflammatory syndromes and unexplained encephalopathy.

Authors/Disclosures
Nishel Y. Kothari, MBBS (Dartmouth-Hitchcock Medical Centre)
PRESENTER
Dr. Kothari has nothing to disclose.
Mohammad Naseem, MBBS Dr. Naseem has nothing to disclose.